AD 32
Term · Oncology and biomedicine · MLC-T-ONC-000223
A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. AD 32 is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. AD 32 is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called valrubicin and Valstar.
| Identifier | MLC-T-ONC-000223 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | valrubicin; Valstar |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000223",
"term": "AD 32",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. AD 32 is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. AD 32 is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called valrubicin and Valstar.",
"synonyms": [
"valrubicin",
"Valstar"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ad-32/"
}
Record 352 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.